Skip to main content

Table 2 Baseline characteristics and 5-year survival predicted and observed in the patients with surgery plus chemotherapy

From: Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience

   

Mean % of 5-Year outcomes

% Delta (Pred-Obs)

 

Number

%

AOL predicted

YTR observed (95% CI)

All patients

765

100

78.19

79.35 (76.3, 82.05)

−1.16

Age

 < 50

177

23.1

83.37

87.57 (81.74, 91.63)

−4.2

 50-59

226

29.5

79.56

80.09 (74.26, 84.73)

−0.53

 60-69

270

35.3

76.51

76.3 (70.76, 80.93)

0.21

 ≥ 70

92

12.1

69.75

70.65 (60.2, 78.84)

−0.9

Sex

 Male

450

58.8

77.57

78.67 (74.59, 82.17)

−1.1

 Female

315

41.2

79.06

80.32 (75.48, 84.3)

−1.26

T stage

 T1

4

0.5

89.50

75 (12.79, 96.05)

14.5

 T2

20

2.6

82.35

85 (60.38, 94.9)

−2.65

 T3

712

93.1

78.78

80.48 (77.37, 83.2)

−1.7

 T4

29

3.8

59.21

48.28 (29.47, 64.78)

10.93

Number of positive node

 0

420

54.9

86.87

86.43 (82.77, 89.36)

0.44

 1-3

242

31.6

74.31

77.27 (71.46, 82.05)

−2.96

 4-10

79

10.3

57.24*

69.62 (58.19, 78.49)

−12.38

 > 10

24

3.2

34.25*

8.33 (1.44, 23.3)

25.92

Number of examined nodes

 1-3

3

0.4

79.33*

100 (100, 100)

−20.67

 4-10

83

10.9

76.77

77.11 (66.49, 84.74)

−0.34

 > 10

679

88.7

78.35

79.53 (76.29, 82.37)

−1.18

Histologic grade

 1

94

12.3

82.44

81.91 (72.53, 88.35)

0.53

 2

561

73.3

78.52

79.14 (75.54, 82.28)

−0.62

 3

44

5.8

69.50

72.73 (57, 83.49)

−3.23

 Undefined

66

8.6

75.09

81.82 (70.21, 89.24)

−6.73

  1. *This predicted estimate is outside the 95% CI of the Kaplan-Meier estimate.
  2. AOL: Adjuvant Online; YTR: Yonsei Tumor registry; CI: confidential interval; Pred: predicted; Obs: observed.